Biotech Acquisition Co - Units (1 Ord Class A & 1/2 War) OverviewBiotech Acquisition Co - Units (1 Ord Class A & 1/2 War) Cost of Revenue
Cost of Revenue analysis for BIOTU.
Quarterly Cost of Revenue
$246572.00
↓ 60.85% YoY
As of Sep 30, 2022
Annual Cost of Revenue (TTM)
$4.98M
↑ 355.42% YoY
Trailing 12 months ending Sep 30, 2022